Investor
After fueling its seed round last year, Health Catalyst Capital Management again lead the startup's funding.
Called Atlas, the tool helps healthcare and research organizations vet wearables and health monitoring devices by their features, validation, usability, security and more.
The funding, led by Foundry Group, is made up of equity and debt.
Founders Fund led the round, which will help the sleep tracking company expand its team and support R&D.
The company is also gradually diversifying its business, with 20% of the expected value of new contracts coming from the non-diabetes business.
The Series C round brings the company's total raise to nearly $52 million.
Despite some wins across its various business efforts, Fitbit's mounting losses provide some insight as to why the company was looking to sell.
The acquisition also gives American Well access to a handful of major provider and payer customers.
The Boston-based company has now raised a hair over $90 million for its AI pathology platform.
Leaps by Bayer led the round, bringing the company's total funding to $50 million.